Evidence for the modulation of the P2f-purinoceptor for extracellular ATP in dissociated rat parotid cells is presented in studies using compounds that inhibit protein kinases. Preincubation of acinar cells with the protein kinase catalytic-site inhibitors K-252a and staurosporine, as well as with the regulatory-domain inhibitor sphingosine, specifically potentiates the elevation in cytosolic Ca2+ concentration ([Ca2+] 
INTRODUCTION
The biological actions of extracellular ATP and the intracellular transduction systems through which these actions are mediated have attracted increasing interest as multiple classes of ATP receptors and numerous responsive tissues have been described (Gordon, 1986) . For example, ATP enhances superoxide formation in stimulated neutrophils (Ward et al., 1988) , activates surfactant phosphatidycholine secretion from alveolar type II cells (Rice et al., 1990) and stimulates histamine secretion from mast cells (Dahlquist and Diamant, 1974) . In cultured human airway epithelia, extracellular ATP increases transepithelial C1-secretion and apical-membrane of C1-permeability, a mechanism that is preserved in cystic-fibrosis airway epithelia which show abnormalities in cyclic-AMP-mediated Cl-secretion (Stutts et al., 1992) . In many cell types ATP increases intracellular free Ca2+ concentration ([Ca2+] 1) through heterotrimeric G-proteins and activation of phospholipase C, as in neutrophils ; Kuroki and Minakani, 1989) and hepatocytes (Charest et al., 1985; Okajima et al., 1987) . In others, it increases [Ca2+]1 by promoting influx of extracellular Ca2+, gating cation channels in lacrimal acinar cells (Sasaki and Gallacher, 1990) , neurons (Bean, 1990; Evans et al., 1992) and vascular smooth muscle (Benham and Tsien, 1987) . P2z purinergic receptors similar to those found in parotid acinar cells are activated exclusively by tetrabasic ATP4-and may mediate specific increases in membrane permeability, as in macrophages (Greenberg et al., 1988) , transformed mouse cell lines (Rozengurt and Heppel, 1979) and mast cells (Cockcroft and Gomperts, 1980 Mg2+ (McMillian et al., 1987b . Examination of the agonist potency series and evidence for the inhibition of the Ca2+ response by elevated concentrations of bivalent cations led to the classification of the purinoceptors in parotid acinar cells as P2z (McMillian et al., 1987b (McMillian et al., , 1993 al., 1988, 1993) . In pilot studies, drugs reported to act at ATP-binding sites of protein kinases were tested to see whether they acted as ATP analogues at the binding site of the parotid-cell purinoceptor. The results of these experiments suggested rather that the drugs might be acting on protein kinases, which in turn modulate the cellular responses to extracellular ATP. Modulation of ATP Abbreviations used: 4-BrA23187, 4-bromo-A23187; 8-BrcAMP, 8-bromo cyclic AMP; [Ca2+] i, cytosolic Ca2+ concentration; CDTA, 1,2-diaminocyclohexane-NNN'N'-tetra-acetic acid; DIDS, 4,4'-di-isothiocyano-2,2'-stilbenedisulphonate; H-7, 1-(5-isoquinolinesulphonyl)-2-methylpiperazine; Iso H-7, 1-(5-isoquinolinesulphonyl)-3-methylpiperazine; IBMX, isobutylmethylxanthine; PKA, protein kinase A (cyclic AMPdependent protein kinase); PKC, protein kinase C; PDBu, 4,f-phorbol 12,13-dibutyrate; W-7, N-(6-aminohexyl)-5-chloro-1-naphthalenesulphonamide.
* To whom correspondence should be addressed. responsivity has not been reported previously. To explore these effects further, the [Ca2+], response to ATP was monitored during treatment with compounds reported to inhibit protein kinase through either the catalytic or the regulatory domain. Comparison of the effects of the drugs on responses activated by ATP and on responses activated via other receptor-or ionophoremediated pathways on the same cells allowed us to explore the specificity of the modulation and to gain insight into the influx or efflux pathways for Ca2+ that are activated by ATP.
EXPERIMENTAL Dissociated acinar-cell preparation
Dissociated parotid acinar cells were prepared by a modification of the method of Kanagasuntheram and Randle (1976) as described previously (McMilian et al., 1987a) . The cell pellet was suspended in Hepes/Ringer buffer of the following composition (in mM): NaCl, 120; KCI, 5; MgCl2, 2.2; CaCl2, 1; Hepes, 20; fl-hydroxybutyrate, 5; glucose, 10; BSA, 0.1 %; pH 7.4. For all experiments the stock solutions of various inhibitors were prepared in dimethyl sulphoxide. The final concentration of dimethyl sulphoxide in the assay was never more than 0.2 % of the volume.
[Ca2+]1 was assayed in cells loaded with 0.5 FM fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR, U.S.A.) (McMillian et al., 1987a) . Washed cells were suspended in Mg2+-free Hepes/Ringer buffer, and 0.5 ml of the cell suspension was added to a cuvette containing 1.5 ml of Mg2+-free Hepes/Ringer buffer that was otherwise identical with the isolation buffer except that the concentration of Ca2+ was elevated to 3 mM to enhance detection of the response to low concentrations of ATP. Fluorescence was measured in a Perkin-Elmer LS5 spectrofluorimeter by using wavelengths of340 and 380 nm for excitation and 505 nm for emission. [Ca2+]1 was estimated by the ratio method, by using a Kd of 224 nM for Ca2+ binding to fura-2 (Grynkiewicz et al., 1985) . Maximum and minimum fluorescence values were obtained by using digitonin (50 .
Plasma-membrane permeability was assayed by monitoring the uptake of ethidium bromide, which shows enhanced fluorescence on binding to nuclear DNA (Tatham et al., 1988) .
Ethidium bromide (20 FM) was added to the cell suspension 1 min before ATP, and the fluorescence was recorded for 15-20 min, with 360 nm and 580 rn as excitation and emission wavelengths respectively. Maximum fluorescence was determined by adding 50 FM digitonin.
Membrane potential was measured with the potential-sensitive dye bis-oxonol (100 nM). Depolarization of the membranes slowly increases the transfer of the dye from the external solution to binding sites inside the cell, thus enhancing its fluorescence (De Togni et al., 1984; Greenberg et al., 1988) . Cells suspended in appropriate solutions (for Na+-free solutions, NaCl was replaced by N-methyl-D-glucamine) were equilibrated for 5 min with bis-oxonol; fluorescence then was measured in the spectrofluorometer at 6 s intervals, by using excitation and emission wavelengths of 540 and 580 nm respectively. The value observed before stimulation was subtracted from the fluorescence signal measured after addition of ATP (300 FM).
Amylase release was determined in cells that were washed three times in warmed oxygenated glucose-free Hepes/Ringer solution and distributed (200 F1 portions) to tubes containing 1 FM 4fl-phorbol 12,13-dibutyrate (PDBu) or buffer. After incubation at 37°C for 60 min, the cells were pelleted and the pellets and supernatants were frozen and thawed and diluted appropriately to give enzyme activity in the linear-response range. Amylase activity was assayed by the method of Bernfeld (1955) . The fraction oftotal amylase released into the supernatant was calculated, and the effect of stimulation was determined by subtracting basal release (no drugs added).
Values are given as means + S.E.M. Experimental values were compared with control values by Student's unpaired twotailed t test. In Tables, asterisks indicate level of significance: *P < 0.05, **P < 0.01, ***P < 0.001.
Fura-2 acetoxymethyl ester, 4-bromo-A23187 (4-BrA23187) and bis-oxonol were obtained from Molecular Probes. ATP [Ca2+] , responses to carbachol and ATP Cells were preincubated with the indicated inhibitors for 10 min before stimulation with agonists. Agonists were tested in the same order as shown in Figure 1 . Values represent percentage of control (no drugs added) and are means± S.E.M. of 8-12 cell preparations for K-252a and 3-5 cell preparations for all other drugs (ND, not determined). Asterisks indicate level of significance: * P < 0.05, ** P < 0.01, *** P < 0.001 compared with response in the absence of inhibitors. Basal [Ca2+] levels were not altered by any of the drugs tested.
( 1 1uM (Table 1) .
Effects of other protein kinase Inhibitors
To test further the hypothesis that the ATP response is specifically potentiated by inhibition of protein kinase, we examined the effects of two other inhibitors of protein kinases: staurosporine, which appears to interact directly with the catalytic site of PKC (Tamaoki et al., 1986) , and sphingosine, which is a regulatorydomain inhibitor of PKC (Merrill and Stevens, 1989; Hannun and Bell, 1989) as well as an inhibitor of calmodulin-dependent enzymes (Jefferson and Schulman, 1988 (Hidaka et al., 1984) , significantly potentiates the response to low concentrations of ATP, but has no effect on the response to high concentrations (Table  1) . However, 100 FM Iso H-7, a structurally related isomer which is a much less effective inhibitor of protein kinases, has no effect at any concentration of ATP (results not shown). With carbachol, pretreatment with staurosporine, sphingosine or H-7 (Table 1) (Lansman et al., 1986) as well as receptor-mediated/non-selective cation channels Hallam et al., 1989; Mertz et al., 1990 ), but it is not a substrate for plasma-membrane Ca-ATPases (Schatzmann, 1975) . When Mn2+ binds to fura-2, it displaces Ca2+ and causes quenching of the fura-2 signal (Grynkiewicz et al., 1985) . Thus the rate of quenching of intracellular fura-2 by Mn2+ can be used as an index of Mn2+ entry and as a measurement of unidirectional cation influx (Prentki et al., 1987) .
Addition of Mn2+ to the cell suspension initially causes a small decrease in fluorescence due to its interaction with extracellular fura-2, which is reversed on addition of CDTA, a membraneimpermeant heavy-metal chelator that binds extracellular Mn2" (results not shown). In control cells, the addition of Mn2+ leads to a small, steady, decline in fluorescence (6.4 + 1.5 % of the basal level/min; n = 3), due to a slow basal rate of entry of Mn2+ into the cells (Figure 2) . Addition of 30 MM ATP accelerates the fall in the fluorescence signal (14.1 +0.42%/min). K-252a pretreatment further enhances the rates of Mn2+ entry in response to ATP (22 + 0.85 %/min) (Figure 2 ). K-252a alone has no effect on the basal rate of Mn2+ entry.
Effects of K-252a on membrane potental Experimental manipulations that modulate the cation-entry pathway stimulated by ATP would also be expected to modulate the depolarization of the cells, which is secondary to the large movements of cations. Our previous studies suggested that both Na+ and Ca2+ enter through an ATP-activated channel (Soltoff et al., 1990a (Soltoff et al., , 1992 , and lead to depolarization of parotid cells. We expected that depolarization would be enhanced by treatments that facilitate the effect of ATP on this channel. Parotidcell membrane potential was measured with the voltage-sensitive dye bis-oxonal. Depolarization by ATP is marked and is potentiated by preincubation with K-252a (Figure 3a) . When Na+ in the extracellular medium is replaced by N-methyl-D-glucamine, ATP is still able to depolarize the cells (Figure 3b ). With normal levels of extracellular Na+, but in the absence of extracellular Ca2+ (nominally Ca2+-free), the extent of depolarization is greater than in the presence of Ca2+ (Figure 3c) . Pretreatment of cells with K252a potentiates the ATP-mediated depolarization in the presence of both Na+ and Ca2+, as well as in the presence of either ion alone. Neither K-252b (Figure 3) nor Iso H-7 (results not shown) has any significant effect on the ATP-mediated change in membrane potential.
Effect of ATP and K-252a on membrane permeability In some cell types, ATP4-increases the permeability to lowmolecular-mass solutes. Although this permeabilizing effect has not been detected in our previous studies, we nonetheless examined the effects of ATP and K-252a on membrane permeability. The uptake of ethidium bromide was assessed at concentrations of ATP ranging from 30 to 600 #M . No increase in permeability to this low-molecular-mass dye is observed on addition of ATP, in either the absence or the presence of K-252a (results not shown).
Effect of K-252a after ATP receptor blockade Experiments were designed to determine whether drugs thought to act by purinoceptor blockade can prevent the effect of K-252a on the [Ca2l], response to ATP. Brilliant Blue G and DIDS block the ATP4-response (Soltoff et al., 1989 (Soltoff et al., , 1990b , and DIDS also blocks [32P]ATP binding in parotid acinar cells (McMillian et al., 1988) . Pretreatment with Brilliant Blue G (1 ,uM) and dihydro-DIDS (100 ,uM), a form of DIDS that does not interfere with fura-2 fluorescence, specifically blocks the ATP4-response, while sparing the small response to low concentrations of ATP. The enhancement of the sensitive ATP/MgATP response by K-252a is preserved, but the ATP4-response is completely blocked (results not shown).
DISCUSSION
In rat parotid acinar cells extracellular ATP elevates [Ca2l] , in a biphasic manner, with a small increase at low concentrations (high affinity) and a large increase at high concentrations (low affinity), consistent with previous results (McMillian et al., 1993) . Based on agonist potency series and other pharmacological evidence, it was previously suggested that two types of P2z purinoceptors are present in parotid acinar cells (McMillian et al., 1993) . In the present paper we show that P2-purinoceptor responses can be modulated by drugs reported to be inhibitors of protein kinases.
Inhibitors of protein kinases may act on either catalytic or regulatory sites of the enzyme, and are for the most part poorly selective for the different types of kinase (Ruegg and Burgess, 1989) . Inhibitors which are directed against the ATP-binding site of the catalytic domain include K-252a and K-252b (Kase et al., 1987) and staurosporine (Tamaoki et al., 1986; Nakadate et al., 1988; Wong et al., 1990) . Sphinogosine is one of the inhibitors which competes with diacylglycerol for binding to the regulatory domain of PKC (Hannun et al., 1986) . Pretreatment of parotid acinar cells with K-252a, a membrane-permeant drug, potentiates the [Ca2+] response mediated by both the low-and high-affinity ATP receptors without altering the muscarinic response mediated by InsP3 formation. The membrane-impermeant analogue K252b is inactive, and preincubation with K-252a is required for the potentiation to develop, indicating that the effects are probably mediated intracellularly. Although the ATP analogues that are most active at the purinoceptor are hydrolysable (McMillian et al., 1993) and therefore are potential phosphodonors for a protein kinase, the requirement for a membranepermeant kinase inhibitor makes it unlikely that the effects are due to inhibition of an ecto-kinase on the cell surface. Further, MgATP2-rather than ATP4-is the preferred substrate for most kinases, and these experiments were carried out in the absence of Mg2+ under conditions optimal for the ATP4-response. Additional evidence for the role of an intracellular kinase comes from the studies with other protein kinase inhibitors, staurosporine, H-7 and sphingosine, which show differential modulatory effects towards either the low-affinity receptor (staurosporine and sphingosine) or the high-affinity receptor (H-7) (Table 1) . Although these selective effects cannot easily be explained at present they demonstrate differential sensitivity of these receptors to modulation by various inhibitors.
Other reports suggest a role for PKC in signal transduction by purinoceptors in various cell types. P2,-purinoceptor-mediated elevation of [Ca2+] , is reported to be completely blocked in neutrophils and hepatocytes (Charest et al., 1985) by prior incubation with phorbol esters. Recently Rice et al. (1990) reported that sphingosine inhibits surfactant phosphatidylcholine secretion induced by ATP and phorbol esters in alveolar type II cells, implying a role for PKC in regulation of purinoceptor responses. Ca21 mobilization, however, was not altered under the same conditions. Since P2y receptors are linked to the phospholipase C pathway, it is probably that the modulatory effects could be secondary and result from action of these compounds on steps subsequent to phospholipase C activation, rather than to direct effects on the receptors. Our observation that PDBu, a specific activator of PKC, is not able to reverse or block the effects of sphingosine and K-252a on the ATP response in parotid cells indicates that the action of these two drugs may not be due to their effects on PKC. Although the possibility exists that parotid cells are not sensitive to PDBu or that the PKC may not be sensitive to activation by this phorbol ester, this does not seem likely, since PDBu stimulates amylase secretion from similarly prepared cells. Although sphinogosine inhibits PKC in vitro (Hannun et al., 1986) , some effects of sphingosine are not mediated through PKC (Winicov and Gershengorn, 1988; Faucher et al., 1988) . Calmodulin-sensitive enzymes also are reported to be inhibited by sphingosine, as noted above, but the failure of W-7 to alter the ATP response and the observation that K-252a potentiates ATP-mediated Mn2+ influx (in the absence of extracellular Ca2") in parotid cells suggest that Ca2+/calmodulin is not involved. These observations, as well as the lack of any effect of PKA activators, suggests that another, as yet unidentified, cellular kinase may participate in the modulation of the ATP-receptor response.
Other receptors that are modulated by specific protein kinases include the ,?-adrenergic receptor (Benovic et al., 1986 ) and rhodopsin (Wilden et al., 1986) . In these systems receptor phosphorylation also had a desensitizing effect, consistent with what we report here. elevation is secondary to a decrease in Ca2+ efflux and/or sequestration, effects that have been reported to be modulated via phosphorylation (Drummond, 1985; Rink and Sage, 1987; Smallwood et al., 1988; Furukawa et al., 1989; Fukuda et al., 1990; Wang et al., 1991) . Alternatively, Ca2+ entry could be increased, or a combination of modulated entry and efflux could occur.
Several lines of evidence indicate that the effects on the ATP response are due to a specific increase in ATP-mediated cation influx, and not to non-specific membrane permeability changes or a generalized decrease in Ca2+ efflux.
(1) Membrane permeabilization to small molecules by extracellular ATP4-, such as that reported in mast cells and macrophages (Cockcroft and Gomperts, 1980; Bennett et al., 1981; Steinberg et al., 1987; Tatham and Lindau, 1990) al., 1987b Soltoff et al., 1990b (Poggioli and Putney, 1982) . K-252a has no effect on either the peak or the sustained phase of the [Ca2+] , elevation in response to carbachol, or the recovery to baseline in Ca2l-free medium, indicating the specificity of its effects on the purinergic response.
( (McMillian et al., 1987b) . Bivalent-cation entry stimulated by ATP was enhanced by K-252a, as evident from the accelerated rate of quenching of fura-2 in the presence of extracellular Mn2 , thus directly demonstrating that potentiation of the ATP response is due to enhanced cation influx.
(5) Cation entry can also be followed by measuring cell depolarization. Cation channels have been implicated in the mechanism of ATP activation in other cells (Krishtal et al., 1983; Nakazawa and Matsuki, 1987; Friel and Bean, 1988) , including lacrimal acinar cells (Sasaki and Gallacher, 1990) . Electrophysiological studies in parotid cells also provide evidence for the presence of a non-selective cation channel permeable to Ca2+ and Na+ that is activated by ATP (McMillian et al., 1988; Soltoff et al., 1990a) . Activation of such a channel leads to membrane depolarization in the presence of extracellular Ca2+ and Na+ concentrations that exceed the intracellular concentrations, but depolarization itself does not activate Ca2+ entry (Soltoff et al., 1992) . As shown previously, ATP depolarizes parotid cells, as measured by bis-oxonol fluorescence, in the presence of either Ca2+ or Na+. More importantly, pretreatment with K-252a enhances ATP-induced depolarization, a further demonstration that the effect of the drug is to enhance cation entry through an ATP-activated cation channel.
Collectively, these results agree with the interpretation that the modulatory effects of K-252a are specific to ATP and that the site of action may be at the ATP-mediated cation-influx channel and/or channel/receptor complex. This interpretation is further supported by the effects of Brilliant Blue G and DIDS, which have been shown previously to block the ATP4-response and [32P]ATP binding in parotid acinar cells (Soltoff et al., 1989; McMillian et al., 1993) . K-252a is ineffective at the low-affinity site when ATP4-receptors are blocked by Brilliant Blue G or dihydro-DIDS. Thus the receptor site occupied by ATP and competed for by DIDS and Brilliant Blue G seems to be essential for the modulatory effects of K-252a on the ATP4-response, but modulation of the high-affinity site persists under these conditions, reinforcing the evidence for independent activation and regulation of two receptors.
Our results with these inhibitory drugs suggest that P2z responses/purinoceptors are specifically modulated by protein kinase(s). A possible mechanism for regulation is that the receptor (or a protein that regulates it) cycles through phosphorylated and dephosphorylated states, which are differentially sensitive to activation by ATP. Potentiation of the response by inhibitors of protein kinases suggests that the dephosphorylated receptor (or modulator) is more readily activated by ATP. The possibility that the drugs are acting at a different site cannot be ruled out at present. Since all of the effective drugs are hydrophobic, it is possible that they interact with sites on the cytosolic face of the membrane in the vicinity of the receptor, although a hydrophobic isomer of H-7 is ineffective. Further experiments examining phosphorylation of the purified components of this system will be required to explore this hypothesis.
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